12:00 AM
 | 
Jul 10, 2000
 |  BC Week In Review  |  Company News  |  Deals

Abbott, Eisai deal

ABT will develop and market Eisai's E70101 orally available oncology therapeutic that halts cell mitosis in tumors. Abbott...

Read the full 68 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >